Tom Gayner Markel Group
Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$10.8M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$10.7M |
| 3 |
Analog Devices
ADI
|
+$8.55M |
| 4 |
SRCL
Stericycle Inc
SRCL
|
+$6.83M |
| 5 |
Texas Instruments
TXN
|
+$4.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$24.5M |
| 2 |
LLTC
Linear Technology Corp
LLTC
|
+$12.8M |
| 3 |
CSX Corp
CSX
|
+$5.03M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$2.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.38% |
| 2 | Consumer Discretionary | 16.72% |
| 3 | Healthcare | 11.82% |
| 4 | Industrials | 10.55% |
| 5 | Communication Services | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
26
Marsh
MRSH
$91.6B
| $45M | 1.01% |
609,500
| – | – |
|
|
MON
27
DELISTED
Monsanto Co
MON
| $44.9M | 1.01% |
396,700
| – | – |
|
28
Enovis
ENOV
$1.5B
| $44.6M | 1% |
659,476
| – | – |
|
|
SCHW
29
Charles Schwab
SCHW
$194B
| $43.1M | 0.97% |
1,057,000
| – | – |
|
|
30
Analog Devices
ADI
$182B
| $41M | 0.92% |
500,811
+108,811
| +28% | +$8.55M |
|
31
Brown-Forman Class A
BF.A
$13.3B
| $39.7M | 0.89% |
1,053,750
| – | – |
|
32
3M
MMM
$92.3B
| $39M | 0.88% |
243,984
| – | – |
|
|
33
Texas Instruments
TXN
$241B
| $38.2M | 0.86% |
474,000
+59,000
| +14% | +$4.57M |
|
34
Travelers Companies
TRV
$75.8B
| $38M | 0.86% |
315,000
| – | – |
|
35
Elevance Health
ELV
$86.9B
| $37M | 0.83% |
224,000
| – | – |
|
|
NVO
36
Novo Nordisk
NVO
$207B
| $36.9M | 0.83% |
2,150,000
| – | – |
|
37
Hasbro
HAS
$13.2B
| $36.3M | 0.82% |
364,000
| – | – |
|
|
ITIC
38
Investors Title Co
ITIC
$546M
| $33.7M | 0.76% |
213,300
| – | – |
|
|
OAK
39
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $33.1M | 0.75% |
730,500
+35,000
| +5% | +$1.53M |
|
40
Moody's
MCO
$87.2B
| $32.5M | 0.73% |
290,000
| – | – |
|
41
American Express
AXP
$227B
| $30.5M | 0.69% |
386,000
| – | – |
|
42
Illinois Tool Works
ITW
$80.4B
| $30.5M | 0.69% |
230,000
| – | – |
|
43
Watsco Inc
WSO
$12.9B
| $28.4M | 0.64% |
198,500
+9,500
| +5% | +$1.42M |
|
44
Factset
FDS
$10.7B
| $27M | 0.61% |
164,000
| – | – |
|
|
DISCK
45
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $26.4M | 0.59% |
931,000
+39,000
| +4% | +$1.07M |
|
46
Ecolab
ECL
$78.9B
| $25.8M | 0.58% |
205,800
+14,000
| +7% | +$1.71M |
|
47
Caterpillar
CAT
$381B
| $25.8M | 0.58% |
278,000
| – | – |
|
48
Norfolk Southern
NSC
$78.8B
| $25.7M | 0.58% |
229,500
| – | – |
|
49
T. Rowe Price
TROW
$23.8B
| $21.4M | 0.48% |
314,000
| – | – |
|
50
CVS Health
CVS
$119B
| $20.7M | 0.47% |
264,000
+16,000
| +6% | +$1.28M |
|
Similar funds
Tom Gayner's Q1 2017 Portfolio in Review
As of Q1 2017, Tom Gayner held 137 positions worth $4.44B, up 7% from $4.15B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Tom Gayner's Q1 2017 filing shows 4 new, 54 increased and 4 closed positions. Its largest new stake was Healthcare Services Group: 55,000 shares worth $2.37M. The largest sale was Oracle, an estimated $24.5M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Tom Gayner's largest Q1 2017 buy was Healthcare Services Group: 55,000 shares worth $2.37M.
- Tom Gayner added most to Amazon in Q1 2017, an estimated $10.8M increase.
- Tom Gayner fully exited Oracle in Q1 2017, selling an estimated $24.5M.
- Tom Gayner's ten largest holdings make up 43% of its $4.44B portfolio in Q1 2017.
- Tom Gayner opened 4 new positions and closed 4 in Q1 2017.
- Tom Gayner's portfolio value rose 7% quarter-over-quarter to $4.44B.
Based on Markel Group's 13F filing for Q1 2017, filed 28 Apr 2017.